Iridian Asset Management LLC Charles River Laboratories International, Inc. Transaction History
Iridian Asset Management LLC
- $239 Million
- Q3 2025
A detailed history of Iridian Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 28,626 shares of CRL stock, worth $4.8 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
28,626
Previous 47,566
39.82%
Holding current value
$4.8 Million
Previous $7.22 Million
37.95%
% of portfolio
1.88%
Previous 2.62%
Shares
24 transactions
Others Institutions Holding CRL
# of Institutions
644Shares Held
51.7MCall Options Held
201KPut Options Held
179K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...